Earnings calls

Curis Lifesciences Ltd concall ledger

Every earnings call for CURIS — management tone, guidance, KPIs and promise tracking, quarter by quarter.

CURIS · 2 transcripts · Healthcare · latest Q2 FY26

Curis Lifesciences Ltd has 2 earnings calls on record here, a Healthcare company, most recently Q2 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.

Q2 FY26Published 22 Jan 2026Call held 22 Jan 2026

CURIS Q2 FY26 Earnings Call Transcript & Analysis

Revenue2,791.01 lakhsEBITDA599.96 lakhsEBITDA Margin21.46%PAT421.13 lakhsPAT Margin15.09%

Revenue 2791.01 lakhs; EBITDA 599.96 lakhs; EBITDA Margin 21.46%. Revenue for Sep 2025 at 2791.01 lakhs with strong EBITDA margin of 21.46%.

Read full transcript & analysis

Q2 FY26Published 09 Jan 2026Call held 09 Jan 2026

CURIS Q2 FY26 Earnings Call Transcript & Analysis

EBITDA Margin9.8%PAT Margin5.23%

EBITDA Margin 9.8%; PAT Margin 5.23%. H1 FY26 Turnover reached ₹27.91 Crores.

Read full transcript & analysis